Skip to main content
. Author manuscript; available in PMC: 2023 May 15.
Published in final edited form as: Am J Clin Dermatol. 2018 Apr;19(2):181–193. doi: 10.1007/s40257-017-0320-y

Fig. 2.

Fig. 2

Mechanism of checkpoint inhibition. CTLA-4 cytotoxic T-lymphocyte-associated protein 4, MHC major histocompatibility complex, PD-1 programmed cell death protein 1, PD-L1 programmed death-ligand 1, TCR T cell receptor